Skip to main content
Premium Trial:

Request an Annual Quote

Yourgene Health SARS-CoV-2 Test Receives CE-IVD Mark

NEW YORK – Yourgene Health said on Monday that its Clarigene SARS-CoV-2 in vitro diagnostic kit has received the CE-IVD mark for diagnostic use.

The IVD version of the test will be used in Yourgene's high-throughput COVID-19 service lab in Manchester, UK. The test is an RT-qPCR assay, which detects the presence of SARS-CoV-2 viral RNA. It uses two viral RNA targets, nucleocapsid gene N and envelope gene E, which are specific to COVID-19, preventing cross reaction with other coronaviruses, Yourgene said.

In clinical validation, the test achieved greater than 99.9 percent accuracy with no false-positive or false-negative results, it added, while additional studies demonstrated 100 percent repeatability data and an average of greater than 99.7 percent reproducibility.

The Scan

Genetic Ancestry of South America's Indigenous Mapuche Traced

Researchers in Current Biology analyzed genome-wide data from more than five dozen Mapuche individuals to better understand their genetic history.

Study Finds Variants Linked to Diverticular Disease, Presents Polygenic Score

A new study in Cell Genomics reports on more than 150 genetic variants associated with risk of diverticular disease.

Mild, Severe Psoriasis Marked by Different Molecular Features, Spatial Transcriptomic Analysis Finds

A spatial transcriptomics paper in Science Immunology finds differences in cell and signaling pathway activity between mild and severe psoriasis.

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.